drugset / Trial / NCT02703896

Prophylaxis for Aspiration of Gastric Contents.

NCT02703896

Phase 4 Completed 1920 enrolled King Saud University
RandomizedParallel-groupTriple-blindPrevention

Summary

Effect of orally administered two equal and consecutive doses of proton pump inhibitors, omeprazole, lansoprazole, esomeprazole , rabeprazole and pantoprazole and Histamine 2 receptor antagonists cimetidine, ranitidine,famotidine,nizatidine and lafutidine without and with a prokinetic agents domperidone, metoclopramide and erythromycin on intragastric pH, volume and bile refluxate.

Timeline

Start
2012-01
Primary completion
2012-01
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cimetidine Small molecule 200 mg Oral
Subject Drug either PPIS or H2RA and prokinetics Unknown 10 mg Oral
Subject Esomeprazole Small molecule 20 mg Oral
Subject Famotidine Other / unclassified 20 mg Oral
Subject Lafutidine Small molecule 10 mg Oral
Subject Lansoprazole Other / unclassified 15 mg Oral
Subject Metoclopramide Small molecule 10 mg Oral
Subject Nizatidine Small molecule 150 mg Oral
Subject Omeprazole Other / unclassified 20 mg Oral
Subject Pantoprazole Other / unclassified 20 mg Oral
Subject Rabeprazole Small molecule 10 mg Oral
Subject Ranitidine Unknown 150 mg Oral

Indications